Valuation: Camurus AB

Market Cap 38.03B 3.94B 3.45B 3.19B 2.93B 5.54B 380B 5.64B 14.9B 186B 14.81B 14.48B 646B P/E 2026 *
40x
P/E 2027 * 25.8x
Enterprise Value 33.46B 3.47B 3.03B 2.81B 2.58B 4.88B 334B 4.96B 13.11B 163B 13.03B 12.75B 568B EV / Sales 2026 *
11.8x
EV / Sales 2027 * 8.5x
Free-Float
67.52%
Yield 2026 *
-
Yield 2027 * -
1 day+3.90%
1 week+14.41%
Current month+13.00%
1 month+16.61%
3 months+18.44%
6 months-6.99%
Current year+3.73%
1 week 525.5
Extreme 525.5
639
1 month 505
Extreme 505
639
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 275
Extreme 275
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap.
2/27/26 A Sell

Chief Executive Officer

9,950 0.0166%
2/27/26 A Sell

Chief Executive Officer

1,500 0.0025%
2/27/26 A Sell

Chief Executive Officer

55,550 0.0928%
Change 5-day change 1-year change 3-year change Capi.($)
+3.90%+14.41%-6.10%+132.53% 3.8B
+1.08%-3.84%+51.50%+160.13% 1,031B
+1.19%-5.10%+61.09%+56.36% 595B
+4.21%+0.65%+36.48%+87.04% 431B
+0.42%-0.99%+30.04%+22.27% 326B
+1.03%-2.10%+28.32%+45.08% 277B
+0.49%-11.32%+20.31%+22.32% 263B
+1.59%+3.91%-22.47%-36.84% 224B
+3.70%+0.98%+27.03%+63.38% 193B
+3.49%+0.35%+24.98%+76.58% 164B
Average +0.82%-2.40%+25.12%+62.88% 350.81B
Weighted average by Cap. +0.17%-4.29%+37.75%+79.49%

Financials

2026 *2027 *
Net sales 2.85B 295M 258M 239M 219M 415M 28.45B 422M 1.12B 13.9B 1.11B 1.08B 48.33B 3.79B 393M 343M 318M 292M 552M 37.88B 562M 1.49B 18.51B 1.48B 1.44B 64.36B
Net income 968M 100M 87.73M 81.22M 74.54M 141M 9.67B 144M 379M 4.73B 377M 369M 16.44B 1.45B 151M 132M 122M 112M 212M 14.52B 216M 570M 7.1B 566M 553M 24.67B
Net Debt -4.56B -473M -414M -383M -351M -665M -45.6B -677M -1.79B -22.29B -1.78B -1.74B -77.48B -5.81B -602M -526M -487M -447M -846M -58.03B -861M -2.28B -28.36B -2.26B -2.21B -98.59B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
308
Date Price Change Volume
16/07/26 SEK 639.00 +3.90% 109,880
15/07/26 SEK 615.00 +16.81% 380,833
14/07/26 SEK 526.50 -2.05% 69,616
13/07/26 SEK 537.50 -3.07% 72,062
10/07/26 SEK 554.50 +0.82% 101,864
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
639.00SEK
Average target price
776.75SEK
Spread / Average Target
+21.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock